As the domestic stock market entered a steep decline on the afternoon of the 22nd, most HLB Group affiliates are trending downward, drawing investors' attention.

[Stock Prices by Issue: HLB Genex Posts Comparably Large Drop] As of 1:37 p.m. on the 22nd, HLB (028300) is trading at 41,300 won, down 2.47% from the previous day. At the same time, HLB Pharmaceutical (047920) is down 4.06% at 10,150 won, and HLB Life Science (067630) is down 4.31% at 3,545 won. HLB Innovation (024850) is down 4.88% at 15,970 won, and HLB Global (003580) is down 4.51% at 1,924 won.

The remaining affiliates are also mostly weak. HLB Genex (187420) is down 5.04% at 2,260 won, showing a comparatively large decline among major group stocks. HLB Panagene (046210) is down 3.77% at 1,402 won, and HLB Fem (196300) is down 2.33% at 4,180 won. HLB Biostep (278650) is down 1.49% at 5,920 won. Among these, only HLB Therapeutics (115450) is holding steady at 2,710 won.

[Broad Market Decline… KOSPI Plunges 3.55%] The weakness in group stocks this day tracks the broader market decline. As of 1:37 p.m., the KOSPI is down 203.85 points (3.55%) from the previous day at 5,531.81. The KOSDAQ is also down 22.55 points (2.84%) at 770.21.

The key point to watch is whether HLB and its affiliates can narrow their losses in the remaining trading hours, or whether the weakness will continue through the close.

Meanwhile, bio-related stocks can see increased price volatility depending on clinical trial results, regulatory reviews, and business progress, so investors should exercise caution.

[※ This article is based on prices as of 1:37 p.m. on the 22nd, and intraday stock prices and indices are subject to change. Investment decisions and their consequences are the responsibility of the investor.]